These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 24247787)
1. Inactive C8A‑humanin analog is as stable as a potent S14G‑humanin analog. Arakawa T; Niikura T; Kita Y Mol Med Rep; 2014 Jan; 9(1):375-9. PubMed ID: 24247787 [TBL] [Abstract][Full Text] [Related]
2. Structure of three Humanin peptides with different activities upon interaction with liposome. Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y Int J Biol Macromol; 2011 Mar; 48(2):360-3. PubMed ID: 21215775 [TBL] [Abstract][Full Text] [Related]
3. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity. Arisaka F; Arakawa T; Niikura T; Kita Y Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035 [TBL] [Abstract][Full Text] [Related]
4. The biological activity of Humanin analogs correlates with structure stabilities in solution. Arakawa T; Niikura T; Kita Y Int J Biol Macromol; 2011 Jul; 49(1):93-7. PubMed ID: 21510972 [TBL] [Abstract][Full Text] [Related]
5. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule. Arisaka F; Niikura T; Arakawa T; Kita Y Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318 [TBL] [Abstract][Full Text] [Related]
6. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism. Arakawa T; Niikura T; Tajima H; Kita Y J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886 [TBL] [Abstract][Full Text] [Related]
7. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog. Arakawa T; Niikura T; Arisaka F; Kita Y J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638 [TBL] [Abstract][Full Text] [Related]
8. Structural preferences of neuroprotective S14G-humanin peptide analyzed by molecular modeling and circular dichroism. Rojo-Domínguez A; Ramírez-Galicia G; Havel J; Gutiérrez-González LH Protein Pept Lett; 2007; 14(6):618-24. PubMed ID: 17627606 [TBL] [Abstract][Full Text] [Related]
9. Humanin structural versatility and interaction with model cerebral cortex membranes. Pistolesi S; Rossini L; Ferro E; Basosi R; Trabalzini L; Pogni R Biochemistry; 2009 Jun; 48(22):5026-33. PubMed ID: 19378954 [TBL] [Abstract][Full Text] [Related]
10. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease. Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M Biochem Biophys Res Commun; 2006 Oct; 349(2):634-42. PubMed ID: 16945331 [TBL] [Abstract][Full Text] [Related]
12. Structure changes of natively disordered Humanin in the presence of lipid. Hirano A; Shiraki K; Niikura T; Arakawa T; Kita Y Int J Biol Macromol; 2010 Apr; 46(3):375-9. PubMed ID: 20116397 [TBL] [Abstract][Full Text] [Related]
13. Advances in characterization of neuroprotective peptide, humanin. Arakawa T; Hirano A; Shiraki K; Niikura T; Kita Y Curr Med Chem; 2011; 18(36):5554-63. PubMed ID: 22172065 [TBL] [Abstract][Full Text] [Related]
14. In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives. Evangelou A; Zikos C; Benaki D; Pelecanou M; Bouziotis P; Papadopoulos M; Borovickova L; Vesela I; Elbert T; Kunesová G; Pirmettis I; Paravatou-Petsotas M; Slaninová J; Livaniou E Peptides; 2009 Dec; 30(12):2409-17. PubMed ID: 19666070 [TBL] [Abstract][Full Text] [Related]
15. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity. Romeo M; Stravalaci M; Beeg M; Rossi A; Fiordaliso F; Corbelli A; Salmona M; Gobbi M; Cagnotto A; Diomede L J Alzheimers Dis; 2017; 57(3):857-871. PubMed ID: 28282805 [TBL] [Abstract][Full Text] [Related]
16. Interaction structure of the complex between neuroprotective factor humanin and Alzheimer's β-amyloid peptide revealed by affinity mass spectrometry and molecular modeling. Maftei M; Tian X; Manea M; Exner TE; Schwanzar D; von Arnim CA; Przybylski M J Pept Sci; 2012 Jun; 18(6):373-82. PubMed ID: 22522311 [TBL] [Abstract][Full Text] [Related]
17. [Humanin and its derivatives as peptides with potential antiapoptotic and confirmed neuroprotective activities]. Zapała B; Staszel T; Kieć-Wilk B; Polus A; Knapp A; Wybrańska I; Kaczyński Ł; Dembińska-Kieć A Przegl Lek; 2011; 68(7):372-7. PubMed ID: 22010475 [TBL] [Abstract][Full Text] [Related]
18. Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase. Glass DB; Trewhella J; Mitchell RD; Walsh DA Protein Sci; 1995 Mar; 4(3):405-15. PubMed ID: 7795524 [TBL] [Abstract][Full Text] [Related]
19. Structural characterization of a neuroblast-specific phosphorylated region of MARCKS. Tinoco LW; Fraga JL; Anobom CD; Zolessi FR; Obal G; Toledo A; Pritsch O; Arruti C Biochim Biophys Acta; 2014 Apr; 1844(4):837-49. PubMed ID: 24590112 [TBL] [Abstract][Full Text] [Related]
20. CE study of neuroprotective humanin peptide and its derivatives: interactions with phosphate, sulphate, alkylsulphonates and sulphated-beta-CD. Havel J; Li R; Macka M Electrophoresis; 2008 Feb; 29(3):665-71. PubMed ID: 18203257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]